Kugiyama, Kiyotaka

Hyperglycemia rapidly suppresses flow-mediated endothelium- dependent vasodilation of brachial artery

Kawano, H., Motoyama, T., Hirashima, O., Hirai, N., Miyao, Y., Sakamoto, T., Kugiyama, K., Ogawa, H., & Yasue, H. (1999) · Journal of the American College of Cardiology

Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease Prevention

Cited by 676

Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease

Kugiyama, K., Doi, H., Takazoe, K., Kawano, H., Soejima, H., Mizuno, Y., Tsunoda, R., Sakamoto, T., Nakano, T., Nakajima, K., et al. (1999) · Circulation

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 284

Remnant Lipoproteins Induce Proatherothrombogenic Molecules in Endothelial Cells Through a Redox-Sensitive Mechanism

Doi, H., Kugiyama, K., Oka, H., Sugiyama, S., Ogata, N., Koide, S.-I., Nakamura, S.-I., & Yasue, H. (2000) · Circulation

Atherosclerosis and Cardiovascular DiseasesNitric Oxide and Endothelin Effects

Cited by 227

Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart

Fujioka, D., Kawabata, K.-I., Saito, Y., Kobayashi, T., Nakamura, T., Kodama, Y., Takano, H., Obata, J.-E., Kitta, Y., Umetani, K., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology

Adipokines, Inflammation, and Metabolic DiseasesCardiac Fibrosis and Remodeling

Cited by 115

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus

Fukushima, H., Sugiyama, S., Honda, O., Koide, S., Nakamura, S., Sakamoto, T., Yoshimura, M., Ogawa, H., Fujioka, D., & Kugiyama, K. (2004) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 91

Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome.

Nakamura, T., Takano, H., Umetani, K., Kawabata, K.-I., Obata, J.-E., Kitta, Y., Kodama, Y., Mende, A., Ichigi, Y., Fujioka, D., et al. (2005) · Atherosclerosis

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

Cited by 90

Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals

Nakamura, T., Obata, J.-E., Hirano, M., Kitta, Y., Fujioka, D., Saito, Y., Kawabata, K.-I., Watanabe, K., Watanabe, Y., Mishina, H., et al. (2011) · Atherosclerosis

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 83

Short-term progression of maximum intima-media thickness of carotid plaque is associated with future coronary events in patients with coronary artery disease

Hirano, M., Nakamura, T., Kitta, Y., Takishima, I., Deyama, J., Kobayashi, T., Fujioka, D., Saito, Y., Watanabe, K., Watanabe, Y., et al. (2011) · Atherosclerosis

Cardiovascular Health and Disease PreventionCerebrovascular and Carotid Artery Diseases

Cited by 34

High Remnant Lipoprotein Predicts Recurrent Cardiovascular Events on Statin Treatment After Acute Coronary Syndrome

Nguyen, S. V., Nakamura, T., & Kugiyama, K. (2014) · Circulation Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 34

Remnant lipoproteinemia predicts cardiovascular events in patients with type 2 diabetes and chronic kidney disease

Nguyen, S. V., Nakamura, T., Uematsu, M., Fujioka, D., Watanabe, K., Watanabe, Y., Obata, J.-E., Nakamura, K., & Kugiyama, K. (2017) · Journal of Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

Cited by 33